Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 14;2(2):1312-27.
doi: 10.3390/cancers2021312.

Serum biomarkers for early detection of gynecologic cancers

Yutaka Ueda  1 , Takayuki Enomoto, Toshihiro Kimura, Takashi Miyatake, Kiyoshi Yoshino, Masami Fujita, Tadashi Kimura
Affiliations

Serum biomarkers for early detection of gynecologic cancers

Yutaka Ueda et al. Cancers (Basel). .

Abstract

Ovarian, endometrial, and cervical cancers are three of the most common malignancies of the female reproductive organs. CA 125, historically the most reliable serum marker for ovarian cancer, is elevated in 50% of early-stage ovarian tumors. For endometrial cancers, there are no established serum markers. SCC, which is the best studied serum marker for squamous cell carcinomas, has been unreliable; SCC is elevated in cervical squamous cell carcinomas ranging from 28-85% of the time. Recent proteomics-based analyses show great promise for the discovery of new and more useful biomarkers. In this review, we will discuss the currently utilized serum tumor markers for gynecologic cancers and the novel biomarkers that are now under investigation.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention. Gynecologic Cancers. [(accessed on 1 March 2010)]. Available online: http://www.cdc.gov/cancer/gynecologic/index.htm.
    1. Nam J.H., Chang K.C., Chambers J.T., Schwartz P.E., Cole L.A. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers. Gynecol. Oncol. 1990;38:66–70. doi: 10.1016/0090-8258(90)90013-B. - DOI - PubMed
    1. Pectasides D., Economides N., Bourazanis J., Pozadzizou P., Gogou L., Koutsiouba P., Athanassiou A. Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer. Am. J. Clin. Oncol. 1994;17:307–312. doi: 10.1097/00000421-199408000-00005. - DOI - PubMed
    1. DiSaia P.J., Creasman W.T. Clinical Gynecologic Oncology. 6th ed. Mosby; St. Louis, MO, USA: 2002. pp. 53–112, 137–184, 259–350.
    1. Berek J.S., editor. Novak's Gynecology. 13th ed. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2002. pp. 1143–1398.